Assay Implementation

我们的中心现在在开发基于细胞和微珠的检测方面拥有广泛的经验 如目标团队进度报告所述。我们有13名经过实验室培训的高级 员工包括9名博士，3名硕士和1名学士。其中11名工作人员具有流式细胞术AD/A的经验 其中11名员工拥有HTS机器人技术的经验，包括2名曾在化学图书馆工作过的员工。 由于我们中心通过MLSCN将流式细胞术的HT多路复用引入科学界， 我们的团队成员支持外展，以开发一个目标管道，可以无限延伸到 未来Sklar、Prossnitz和Edwards已经做了超过60次的外联演讲，以突出路线图的目标， 机会几乎所有检测都涉及目标提供商和我们中心之间的合作。 在迄今为止提交的测定中，除了VLA-4和Quorom传感测定之外，基本上所有测定都需要一个时间间隔。 发展阶段。

Our Center now has a broad range of experience in developing cell and bead based assays for the flow cytometer As summarized in target team progress report. We have 13 laboratory trained senior staff including 9PhDs, 3 MSs, and 1 BS. Eleven of these staff have experience in AD/A with flow cytometry and 11 of these staff have experience in HTS robotics including 2 who have worked with chemical libraries. Since HT multiplexing by flow cytometry was introduced to the scientific community by our Center via MLSCN, our team members have supported outreach to develop a target pipeline that can extend indefinitely into the future. Sklar, Prossnitz, and Edwards have given >60 outreach presentations to highlight Roadmap targets and opportunities. Nearly all of the assays involve collaborations between the target provider and our Center. Among the assays submitted so far, essentially all but the VLA-4 and Quorom Sensing assays required a development phase.